| Health / Medical Topics |
Liposome-Incorporated Grb2 Antisense Oligodeoxynucleotide
A liposomal formulation containing the antisense oligodeoxynucleotide (ODN) growth factor receptor-bound protein 2 (Grb2), with potential antineoplastic activity. Upon administration, liposome-incorporated Grb2 antisense oligodeoxynucleotide binds directly to and blocks Grb2 mRNA, thereby preventing Grb2 protein synthesis, leading to inhibition of cell proliferation of cancer cells overexpressing Grb2. Grb2, an adaptor protein involved in growth signaling pathways, is upregulated in certain tumor cells. (NCI Thesaurus)
YOU MAY ALSO LIKE
A topical hydrophilic gel containing a recombinant form of the human Cu/Zn superoxide dismutase (SOD1), a cytoplasmic antioxidant enzyme, encapsulated in liposomes…
A systemic gene therapy anti-cancer agent composed of cationic liposomes, which encapsulates plasmid DNA encoding for the tumor suppressor gene RB94 and…
A liposomal formulation containing a nucleotide that mimics the human tumor suppressor microRNA (miRNA) miR-34, with potential antineoplastic activity. Upon administration, liposome-encapsulated…
A form of the anticancer drug irinotecan hydrochloride that is contained inside very tiny, fat-like particles. It is being studied in the…
A form of the anticancer drug doxorubicin citrate that is contained inside very tiny, fat-like particles. It is being studied in the…
A microscopic vesicle consisting of one or more phospholipid layers surrounding an aqueous core. Liposomes can be utilized to facilitate the delivery…
